121 related articles for article (PubMed ID: 22651562)
1. Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients.
Waszczuk-Jankowska M; Markuszewski MJ; Markuszewski M; Kaliszan R
Bioanalysis; 2012 Jun; 4(10):1185-94. PubMed ID: 22651562
[TBL] [Abstract][Full Text] [Related]
2. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
3. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
4. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
[TBL] [Abstract][Full Text] [Related]
5. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
Xu G; Schmid HR; Lu X; Liebich HM; Lu P
Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
[TBL] [Abstract][Full Text] [Related]
7. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers.
Struck W; Siluk D; Yumba-Mpanga A; Markuszewski M; Kaliszan R; Markuszewski MJ
J Chromatogr A; 2013 Mar; 1283():122-31. PubMed ID: 23465127
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of urinary nucleosides and creatinine assay by capillary electrophoresis with solid phase extraction.
Szymańska E; Markuszewski MJ; Bodzioch K; Kaliszan R
J Pharm Biomed Anal; 2007 Sep; 44(5):1118-26. PubMed ID: 17590562
[TBL] [Abstract][Full Text] [Related]
9. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Lin WD; Tsai Y; Lin CT; Wang HC; Jeng LB; Lee CC; Lin YC; Lai CC; Tsai FJ
Clin Chim Acta; 2011 Sep; 412(19-20):1861-6. PubMed ID: 21740897
[TBL] [Abstract][Full Text] [Related]
10. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides.
Seidel P; Seidel A; Herbarth O
Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256
[TBL] [Abstract][Full Text] [Related]
11. [Significance of urinary nucleosides in diagnosis of gastric carcinoma].
Chen YJ; Zheng YF; Wang NF; Lu S; Pang T; Yang Q; Xu GW
Ai Zheng; 2003 May; 22(5):537-40. PubMed ID: 12753721
[TBL] [Abstract][Full Text] [Related]
12. Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis.
Szymańska E; Markuszewski MJ; Markuszewski M; Kaliszan R
J Pharm Biomed Anal; 2010 Dec; 53(5):1305-12. PubMed ID: 20719449
[TBL] [Abstract][Full Text] [Related]
13. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
[TBL] [Abstract][Full Text] [Related]
14. [Development of high performance liquid chromatographic method using monolithic column for the determination of urinary nucleosides].
Zhao X; Zheng Y; Zhang P; Kong H; Xu G
Se Pu; 2005 Jan; 23(1):73-5. PubMed ID: 15881371
[TBL] [Abstract][Full Text] [Related]
15. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography.
Liebich HM; Müller-Hagedorn S; Bacher M; Scheel-Walter HG; Lu X; Frickenschmidt A; Kammerer B; Kim KR; Gérard H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):275-83. PubMed ID: 15639449
[TBL] [Abstract][Full Text] [Related]
16. [Lung cancer diagnosis based on urinary modified nucleoside metabolic profiling].
Wang WZ; Zhao XJ; Li X; Chen J; Li FL; Xu GW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):738-41. PubMed ID: 18595249
[TBL] [Abstract][Full Text] [Related]
17. Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique.
Struck-Lewicka W; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2014 Dec; 101():50-7. PubMed ID: 24840632
[TBL] [Abstract][Full Text] [Related]
18. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
[TBL] [Abstract][Full Text] [Related]
19. Patterns of urinary excretion of modified nucleosides.
Gehrke CW; Kuo KC; Waalkes TP; Borek E
Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale ion-pair reversed-phase HPLC-MS for sensitive metabolome analysis.
Kiefer P; Delmotte N; Vorholt JA
Anal Chem; 2011 Feb; 83(3):850-5. PubMed ID: 21166460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
